Anna P. Durbin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans”.

A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans

Nature Communications(2021)10.1038/s41467-021-21384-0

N/A

2.9DataRank · unranked

73 citations

Jesica Swanstrom, Matthew J. Delacruz, B. L. Patel, Anna P. Durbin, Steve Whitehead +7 more

Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00520-0

N/A

1.9DataRank · unranked

46 citations

Mohammad Shafiul Alam, Kristen K. Pierce, Marya P. Carmolli, Masud Alam, Dorothy M. Dickson +11 more

TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies

Journal of Clinical Investigation(2023)10.1172/jci173328

N/A

1.3DataRank · unranked

28 citations

Anna P. Durbin, MaryClaire Walsh, Marya P. Carmolli, Beulah P. Sabundayo, Dorothy M. Dickson +4 more

Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model

Nature Communications(2021)10.1038/s41467-021-22930-6

N/A

1.3DataRank · unranked

35 citations

Huy A. Tu, Julie A. Dragon, Dorothy M. Dickson, Roxana del Río, Scott Tighe +11 more

Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial

American Journal of Tropical Medicine and Hygiene(2020)10.4269/ajtmh.20-0042

N/A

0.895DataRank · unranked

27 citations

Kristen K. Pierce, Beth D. Kirkpatrick, Palmtama L. Grier, Beulah P. Sabundayo, Helen He +11 more

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model

New England Journal of Medicine(2025)10.1056/nejmoa2500179

N/A

0.554DataRank · unranked

12 citations

Liesbeth Van Wesenbeeck, Kristen K. Pierce, Guillermo Herrera‐Taracena, Laura Ebone, Annemie Buelens +22 more

Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine

BMC Infectious Diseases(2023)10.1186/s12879-023-08299-5

N/A

0.220DataRank · unranked

3 citations

Kelsey E. Lowman, Melissa Law, Rosemary A. Aogo, Sally Hunsberger, Bradford J. Wood +13 more

Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model

UNC Libraries(2020)10.17615/8pvm-dx28

N/A

0DataRank · unranked

0 citations

Ralph S. Baric, Sean A. Diehl, Bhumi Patel, Beth D. Kirkpatrick, Huy A. Tu +9 more

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination

UNC Libraries(2020)10.17615/zp6f-ax33

N/A

0DataRank · unranked

0 citations

Aravinda M. de Silva, Ralph S. Baric, Nurgun Kose, Alessandro Sette, Douglas G. Widman +9 more

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization

UNC Libraries(2020)10.17615/4ntf-3q10

N/A

0DataRank · unranked

0 citations

Anna P. Durbin, Usha K. Nivarthi, Douglas G. Widman, Rachel L. Graham, Thomas J. Baric +6 more

Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity

UNC Libraries(2020)10.17615/7een-qn15

N/A

0DataRank · unranked

0 citations

Mary Jane Cardosa, Robert B. Tesh, Shannan L. Rossi, José Ramos‐Castañeda, Anna P. Durbin +7 more

Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity

UNC Libraries(2021)10.17615/0mr2-mv67

N/A

0DataRank · unranked

0 citations

Scott C. Weaver, Mary Jane Cardosa, Nikos Vasilakis, Irma Yvonne Amaya-Larios, Shannan L. Rossi +7 more

Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model

Pathogens(2022)10.3390/pathogens11030294

N/A

0DataRank · unranked

14 citations

Tertuliano Alves Pereira Neto, Marcela Helena Gonçalves-Pereira, Ana Carolina Bernardes Terzian, Anna P. Durbin, Helton C. Santiago

Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses

JCI Insight(2022)10.1172/jci.insight.151782

N/A

0DataRank · unranked

6 citations

Kimberly E. Rousseau, Katherine Cascino, Guido Massaccesi, William H. Aisenberg, Wensheng Luo +7 more

Precision arbovirus serology with a pan-arbovirus peptidome

Nature Communications(2024)10.1038/s41467-024-49461-0

N/A

0DataRank · unranked

16 citations

Wan Ni Chia, Beatriz Parra, Daniel R. Monaco, Izabela Ragan, Carlos A. Pardo +9 more

Localized Inflammation in Dengue Vaccine–Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome

Journal of Investigative Dermatology(2024)10.1016/j.jid.2024.11.015

N/A

0DataRank · unranked

2 citations

Nicole A. Bouffard, Olha Smolynets, Nancy R. Graham, Evan A. Elko, Beulah Sabundayo +8 more

T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species

Journal of Virology(2020)10.1128/jvi.00089-20

N/A

0DataRank · unranked

70 citations

Hannah Voic, Sandeep Kumar Dhanda, Conner K. Kidd, James D. Brien, Søren Buus +10 more

Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to development

Vaccine(2025)10.1016/j.vaccine.2025.127938

N/A

0DataRank · unranked

2 citations

Aaron C. Brault, Amy J. Lambert, Sudhakar Agnihothram, Alan D.T. Barrett, Luisa Barzon +12 more

Rapid Induction and Maintenance of Virus-Specific CD8+ TEMRA and CD4+ TEM Cells Following Protective Vaccination Against Dengue Virus Challenge in Humans

Frontiers in Immunology(2020)10.3389/fimmu.2020.00479

N/A

0DataRank · unranked

47 citations

Phil Eisenhauer, Sean A. Diehl, Kristen K. Pierce, Stephen S. Whitehead, Anna P. Durbin +6 more

Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100155

N/A

0DataRank · unranked

12 citations

Usha K. Nivarthi, Nancy R. Graham, Philip Eisenhauer, Matthew J. Delacruz, Kristen K. Pierce +8 more

Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005

Current Opinion in Virology(2020)10.1016/j.coviro.2020.09.005

N/A

0DataRank · unranked

44 citations

Anna P. Durbin

Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics

UNC Libraries(2020)10.17615/asf1-p572

N/A

0DataRank · unranked

1 citations

Aravinda M. de Silva, Stephen S. Whitehead, Scott A. Smith, Nurgun Kose, Ruklanthi de Alwis +2 more

T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.17.911099

N/A

0DataRank · unranked

4 citations

Hannah Voic, Sandeep Kumar Dhanda, Conner K. Kidd, James D. Brien, Søren Buus +10 more

Corrigendum to ‘‘Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model’’ [EBioMedicine 41 (2019) 465–478]

EBioMedicine(2020)10.1016/j.ebiom.2020.102708

N/A

0DataRank · unranked

1 citations

Huy A. Tu, Matthew J. Delacruz, Jesica Swanstrom, B. L. Patel, Anna P. Durbin +9 more